Xenon stock lost 30%, but the FDA story is more complicated
Xenon Pharmaceuticals (XENE) provided investors with two very different updates on the same drug, and Wall Street paid attention to the troubling one. Shares of the Vancouver-based biotech company plummeted as much as 30% on Sept. 18 after Xenon …